About Concordia International
Concordia International is a company based in Oakville (Canada) founded in 2016 by Mark Thompson. It operates as a B2B. The company has 264 employees as of March 31, 2023. Concordia International has completed 1 acquisition, including Amdipharm Mercury. Concordia International operates in a competitive market with competitors including Cardinal Health, CNX Therapeutics, Xiel, Bartec Technologies and SPL Pharma, among others.
- Headquarter Oakville, Canada
- Employees 264 as on 31 Mar, 2023
- Founders Mark Thompson
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Advanz Pharma Services (India) Private Limited
- Date of Incorporation 18 Jun, 1999
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$16.23 M (USD)20.56as on Mar 31, 2023
-
Net Profit
$1.83 M (USD)20.89as on Mar 31, 2023
-
EBITDA
$2.37 M (USD)38.94as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
264
as on Mar 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Concordia International
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Concordia International
Concordia International has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Amdipharm Mercury. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A diversified portfolio of off-patent drugs is provided.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Concordia International
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Concordia International Comparisons
Competitors of Concordia International
Concordia International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, CNX Therapeutics, Xiel, Bartec Technologies and SPL Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple healthcare products and services are provided to organizations.
|
|
| domain | founded_year | HQ Location |
Distributor of specialty drugs
|
|
| domain | founded_year | HQ Location |
Specialist nuclear medicine and radiotherapy solutions are distributed.
|
|
| domain | founded_year | HQ Location |
Mediso: Advanced medical imaging systems and radioactive sources
|
|
| domain | founded_year | HQ Location |
International distribution of specialty medicines and pharmaceutical market access services.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Concordia International
When was Concordia International founded?
Concordia International was founded in 2016.
Where is Concordia International located?
Concordia International is headquartered in Oakville, Canada. It is registered at Oakville, Ontario, Canada.
Who is the current CEO of Concordia International?
Mark Thompson is the current CEO of Concordia International. They have also founded this company.
How many employees does Concordia International have?
As of Mar 31, 2023, the latest employee count at Concordia International is 264.
What is the annual revenue of Concordia International?
Annual revenue of Concordia International is $16.23M as on Mar 31, 2023.
What does Concordia International do?
Concordia International distributes specialty pharmaceutical drugs to healthcare providers through providing healthcare solutions, producing pharmaceutical products, distribution, and specialty drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Concordia International?
Concordia International's top competitors include Cardinal Health, Xiel and CNX Therapeutics.
How many acquisitions has Concordia International made?
Concordia International has made 1 acquisition, including Amdipharm Mercury.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.